Sun Pharmaceutical Industries Limited Unclassified
FDA Approved Drugs

Sun Pharmaceutical Industries Limited Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 41
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
1031
View
Unclassified
41
View
Discontinued
698
View
OTC
21
View
RX
271
View
Company Overview

Company

Sun Pharmaceutical Industries Limited Unclassified

Country

India

Website

Visit Website

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Sun Pharmaceutical Industries Limited Unclassified

Sun House, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063

India

sunpharma.com/ View on Map
FDA Approved Drug Records ( 41 records )
-
Unclassified Application: 78614

Drug Name

ARIPIPRAZOLE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

78614 / 1

Active Ingredient

ARIPIPRAZOLE

Application Number

78614

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78614

Drug Name

ARIPIPRAZOLE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

78614 / 2

Active Ingredient

ARIPIPRAZOLE

Application Number

78614

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78614

Drug Name

ARIPIPRAZOLE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

78614 / 3

Active Ingredient

ARIPIPRAZOLE

Application Number

78614

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78614

Drug Name

ARIPIPRAZOLE

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

-

78614 / 4

Active Ingredient

ARIPIPRAZOLE

Application Number

78614

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78614

Drug Name

ARIPIPRAZOLE

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

-

78614 / 5

Active Ingredient

ARIPIPRAZOLE

Application Number

78614

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 79020

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

79020 / 1

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

79020

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 79020

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

18MG

Approval Date

-

79020 / 2

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

79020

Product Number

2

Dosage Form

-

Strength

18MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 79020

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

25MG

Approval Date

-

79020 / 3

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

79020

Product Number

3

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 79020

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

-

79020 / 4

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

79020

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 79020

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

60MG

Approval Date

-

79020 / 5

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

79020

Product Number

5

Dosage Form

-

Strength

60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 79020

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

6

Dosage Form

-

Strength

80MG

Approval Date

-

79020 / 6

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

79020

Product Number

6

Dosage Form

-

Strength

80MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 79020

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

7

Dosage Form

-

Strength

100MG

Approval Date

-

79020 / 7

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

79020

Product Number

7

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212343

Drug Name

EMPAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

212343 / 1

Active Ingredient

EMPAGLIFLOZIN

Application Number

212343

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212343

Drug Name

EMPAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

212343 / 2

Active Ingredient

EMPAGLIFLOZIN

Application Number

212343

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205032

Drug Name

FESOTERODINE FUMARATE

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

205032 / 1

Active Ingredient

FESOTERODINE FUMARATE

Application Number

205032

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205032

Drug Name

FESOTERODINE FUMARATE

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

-

205032 / 2

Active Ingredient

FESOTERODINE FUMARATE

Application Number

205032

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 77592

Drug Name

GALANTAMINE HYDROBROMIDE

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

77592 / 1

Active Ingredient

GALANTAMINE HYDROBROMIDE

Application Number

77592

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 77592

Drug Name

GALANTAMINE HYDROBROMIDE

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

-

77592 / 2

Active Ingredient

GALANTAMINE HYDROBROMIDE

Application Number

77592

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 77592

Drug Name

GALANTAMINE HYDROBROMIDE

Product Number

3

Dosage Form

-

Strength

12MG

Approval Date

-

77592 / 3

Active Ingredient

GALANTAMINE HYDROBROMIDE

Application Number

77592

Product Number

3

Dosage Form

-

Strength

12MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761067

Drug Name

ILUMYA

Product Number

1

Dosage Form

-

Strength

100MG/1ML

Approval Date

-

761067 / 1

Active Ingredient

TILDRAKIZUMAB-ASMN

Application Number

761067

Product Number

1

Dosage Form

-

Strength

100MG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213092

Drug Name

LENVATINIB

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

213092 / 1

Active Ingredient

LENVATINIB MESYLATE

Application Number

213092

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213092

Drug Name

LENVATINIB

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

213092 / 2

Active Ingredient

LENVATINIB MESYLATE

Application Number

213092

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 215126

Drug Name

LIFITEGRAST

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

-

215126 / 1

Active Ingredient

LIFITEGRAST

Application Number

215126

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208454

Drug Name

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG/500MG

Approval Date

-

208454 / 1

Active Ingredient

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Application Number

208454

Product Number

1

Dosage Form

-

Strength

2.5MG/500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208454

Drug Name

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

2.5MG/850MG

Approval Date

-

208454 / 2

Active Ingredient

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Application Number

208454

Product Number

2

Dosage Form

-

Strength

2.5MG/850MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208454

Drug Name

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

2.5MG/1GM

Approval Date

-

208454 / 3

Active Ingredient

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Application Number

208454

Product Number

3

Dosage Form

-

Strength

2.5MG/1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91118

Drug Name

MINOCYCLINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 55MG BASE

Approval Date

-

91118 / 2

Active Ingredient

MINOCYCLINE HYDROCHLORIDE

Application Number

91118

Product Number

2

Dosage Form

-

Strength

EQ 55MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213107

Drug Name

PALBOCICLIB

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

-

213107 / 1

Active Ingredient

PALBOCICLIB

Application Number

213107

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213107

Drug Name

PALBOCICLIB

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

213107 / 2

Active Ingredient

PALBOCICLIB

Application Number

213107

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213107

Drug Name

PALBOCICLIB

Product Number

3

Dosage Form

-

Strength

125MG

Approval Date

-

213107 / 3

Active Ingredient

PALBOCICLIB

Application Number

213107

Product Number

3

Dosage Form

-

Strength

125MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210232

Drug Name

POMALIDOMIDE

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

-

210232 / 1

Active Ingredient

POMALIDOMIDE

Application Number

210232

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210232

Drug Name

POMALIDOMIDE

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

-

210232 / 2

Active Ingredient

POMALIDOMIDE

Application Number

210232

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210232

Drug Name

POMALIDOMIDE

Product Number

3

Dosage Form

-

Strength

3MG

Approval Date

-

210232 / 3

Active Ingredient

POMALIDOMIDE

Application Number

210232

Product Number

3

Dosage Form

-

Strength

3MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210232

Drug Name

POMALIDOMIDE

Product Number

4

Dosage Form

-

Strength

4MG

Approval Date

-

210232 / 4

Active Ingredient

POMALIDOMIDE

Application Number

210232

Product Number

4

Dosage Form

-

Strength

4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 77571

Drug Name

REPAGLINIDE

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

-

77571 / 1

Active Ingredient

REPAGLINIDE

Application Number

77571

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202423

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

202423 / 1

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202423

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202423

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

202423 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202423

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202423

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

202423 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202423

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 209259

Drug Name

XYROSA

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

209259 / 1

Active Ingredient

DOXYCYCLINE

Application Number

209259

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204051

Drug Name

ZOLEDRONIC ACID

Product Number

1

Dosage Form

-

Strength

4MG/100ML

Approval Date

-

204051 / 1

Active Ingredient

ZOLEDRONIC ACID

Application Number

204051

Product Number

1

Dosage Form

-

Strength

4MG/100ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204138

Drug Name

ZOLEDRONIC ACID

Product Number

1

Dosage Form

-

Strength

5MG/100ML

Approval Date

-

204138 / 1

Active Ingredient

ZOLEDRONIC ACID

Application Number

204138

Product Number

1

Dosage Form

-

Strength

5MG/100ML

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    34 View
  • EDQM CEP
    100 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    6 View
  • FDA Approved Drugs Database
    1,031 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
41 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ARIPIPRAZOLE

Application Number

78614

Product Number

1

Active Ingredient

ARIPIPRAZOLE

Dosage Form

-

Strength

5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit